| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aggressive course of disease in dementia
|
Gauthier, Serge
|
|
2006
|
2 |
3 |
p. 210-217
8 p.
|
artikel
|
| 2 |
Alzheimer’s Association Medical and Scientific Advisory Council
|
|
|
2006
|
2 |
3 |
p. A11-
1 p.
|
artikel
|
| 3 |
Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?
|
Grundman, Michael
|
|
2006
|
2 |
3 |
p. 220-233
14 p.
|
artikel
|
| 4 |
A review of the “State of the Art” on Mild Cognitive Impairment: The Fourth Annual Symposium
|
Bain, Lisa J.
|
|
2006
|
2 |
3 |
p. 246-256
11 p.
|
artikel
|
| 5 |
Commentary on “Aggressive course of disease in dementia”
|
Brandt, Jason
|
|
2006
|
2 |
3 |
p. 218-219
2 p.
|
artikel
|
| 6 |
Commentary on “Comparison of clinical and neuropathologic diagnoses of Alzheimer’s disease in 3 epidemiologic samples”
|
Jellinger, Kurt A.
|
|
2006
|
2 |
3 |
p. 169-170
2 p.
|
artikel
|
| 7 |
Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer’s disease”
|
Siemers, Eric R.
|
|
2006
|
2 |
3 |
p. 140-142
3 p.
|
artikel
|
| 8 |
Commentary on “Vascular cognitive impairment: Today and tomorrow”
|
Markesbery, William R.
|
|
2006
|
2 |
3 |
p. 205-206
2 p.
|
artikel
|
| 9 |
Commentary on “Vascular cognitive impairment: Today and tomorrow”
|
Lopez, Oscar L.
|
|
2006
|
2 |
3 |
p. 200-201
2 p.
|
artikel
|
| 10 |
Commentary on “Vascular cognitive impairment: Today and tomorrow”
|
Bennett, David A.
|
|
2006
|
2 |
3 |
p. 207-209
3 p.
|
artikel
|
| 11 |
Commentary on “Vascular cognitive impairment: Today and tomorrow”
|
Kuller, Lewis H.
|
|
2006
|
2 |
3 |
p. 195-197
3 p.
|
artikel
|
| 12 |
Commentary on “Vascular cognitive impairment: Today and tomorrow.” Vascular cognitive impairment: Time for prevention?
|
Fratiglioni, Laura
|
|
2006
|
2 |
3 |
p. 202-204
3 p.
|
artikel
|
| 13 |
Commentary on “Vascular cognitive impairment: Today and tomorrow.” Vascular cognitive impairment: Yesterday, today, and tomorrow
|
Hachinski, Vladimir
|
|
2006
|
2 |
3 |
p. 198-199
2 p.
|
artikel
|
| 14 |
Contents
|
|
|
2006
|
2 |
3 |
p. A3-
1 p.
|
artikel
|
| 15 |
Contents
|
|
|
2006
|
2 |
3 |
p. A4-
1 p.
|
artikel
|
| 16 |
Correspondence
|
Hachinski, Vladimir
|
|
2006
|
2 |
3 |
p. 261-
1 p.
|
artikel
|
| 17 |
Development of a disease-modifying treatment for Alzheimer’s disease: Alzhemed
|
Aisen, Paul S.
|
|
2006
|
2 |
3 |
p. 153-154
2 p.
|
artikel
|
| 18 |
Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer’s disease
|
Rudick, Richard A.
|
|
2006
|
2 |
3 |
p. 143-146
4 p.
|
artikel
|
| 19 |
Disease-modifying treatments for Alzheimer’s disease: A perspective based on experience with R-Flurbiprofen
|
Wilcock, Gordon K.
|
|
2006
|
2 |
3 |
p. 150-152
3 p.
|
artikel
|
| 20 |
Editorial board
|
|
|
2006
|
2 |
3 |
p. A7-
1 p.
|
artikel
|
| 21 |
Factors associated with gastrostomy tube feeding in dementia: A structured literature review
|
Jones, Elizabeth W.
|
|
2006
|
2 |
3 |
p. 234-242
9 p.
|
artikel
|
| 22 |
Finding potent drugs for Alzheimer’s disease is more important than proving the drugs are disease modifying
|
Knopman, David
|
|
2006
|
2 |
3 |
p. 147-149
3 p.
|
artikel
|
| 23 |
Information for Authors
|
|
|
2006
|
2 |
3 |
p. A13-A15
nvt p.
|
artikel
|
| 24 |
Lessons from osteoporosis clinical trials
|
Silverman, Stuart L.
|
|
2006
|
2 |
3 |
p. 155-159
5 p.
|
artikel
|
| 25 |
Modifying dementia risk and trajectories of cognitive decline in aging: The Cache County Memory Study
|
Welsh-Bohmer, Kathleen A.
|
|
2006
|
2 |
3 |
p. 257-260
4 p.
|
artikel
|
| 26 |
Optimal design of clinical trials for drugs designed to slow the course of Alzheimer’s disease
|
Mohs, Richard C.
|
|
2006
|
2 |
3 |
p. 131-139
9 p.
|
artikel
|
| 27 |
Perspectives on assessing benefits and risks in clinical trials for Alzheimer’s disease
|
McConnell, Stephen
|
|
2006
|
2 |
3 |
p. 160-163
4 p.
|
artikel
|
| 28 |
Policy statement on voting by persons with dementia residing in long-term care facilities
|
Karlawish, Jason
|
|
2006
|
2 |
3 |
p. 243-245
3 p.
|
artikel
|
| 29 |
Research Roundtable Designates Grant, Hosts Invited Meeting on Diverse Treatment Strategies
|
|
|
2006
|
2 |
3 |
p. A17-A18
nvt p.
|
artikel
|
| 30 |
Subscriber information page
|
|
|
2006
|
2 |
3 |
p. A2-
1 p.
|
artikel
|
| 31 |
Telemedicine, dementia and Down syndrome: Implications for Alzheimer disease
|
Lott, Ira T.
|
|
2006
|
2 |
3 |
p. 179-184
6 p.
|
artikel
|
| 32 |
Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy?
|
Franco, Sonia
|
|
2006
|
2 |
3 |
p. 164-168
5 p.
|
artikel
|
| 33 |
The reciprocal risks of stroke and cognitive impairment in an elderly population
|
Jin, Ya-Ping
|
|
2006
|
2 |
3 |
p. 171-178
8 p.
|
artikel
|
| 34 |
Vascular cognitive impairment: Today and tomorrow
|
Chui, Helena Chang
|
|
2006
|
2 |
3 |
p. 185-194
10 p.
|
artikel
|
Tijdschrift beschrijving